Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Pretreatment plasma sCD14 as a prognostic indicator in advanced non-small cell lung cancer patients undergoing immunotherapy

Fig. 1

Differential cytokines between NDB and DCB in the aNSCLC discovery cohort (n = 42). (A) Heatmap depicts the eight differential cytokines in NDB versus DCB patients with aNSCLC. (B) Functional enrichment analysis of the eight cytokines identified. (C) Protein-protein interaction network for the eight differential cytokines. (Abbreviation: NDB: non-durable clinical benefit; DCB: durable clinical benefit; aNSCLC: advanced non-small cell lung cancer; LUAD: lung adenocarcinoma; LUSC; lung squamous cell carcinoma)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us